Meta-analysis shows high-flow nasal cannula improves oxygen saturation and reduces apnea-hypopnea index in adults with obstructive sleep apnea, suggesting a new management approach.
Key Points
HFNC therapy significantly reduces apnea–hypopnea index in adults with obstructive sleep apnea, resulting in better management options.
Pooled analysis showed a mean difference of -8.90 for apnea–hypopnea index and improvements in oxygen saturation levels.
Systematic literature search identified 12 studies focusing on adult OSA patients treated with high-flow nasal cannula therapy and associated outcomes.
Utilizing HFNC may highlight a potential shift in treatment practices for managing obstructive sleep apnea effectively.